Affinity Asset Advisors, LLC Q4 2021 Filing
Filed February 11, 2022
Portfolio Value
$275.4B
Holdings
54
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (54 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MORFMORPHIC HLDG INC | 399,302 | $18.9B | 6.87% | |
| 2 | SWTXSPRINGWORKS THERAPEUTICS INC | 298,545 | $18.5B | 6.72% | |
| 3 | SAVACASSAVA SCIENCES INC | 350,000 | $15.3B | 5.55% | Put |
| 4 | —VINCERX PHARMA INC | 1,135,365 | $11.6B | 4.20% | |
| 5 | NARIUSDINARI MED INC | 125,000 | $11.4B | 4.14% | |
| 6 | ZNTLZENTALIS PHARMACEUTICALS INC | 117,500 | $9.9B | 3.59% | |
| 7 | ARNAEURARENA PHARMACEUTICALS INC | 100,000 | $9.3B | 3.37% | |
| 8 | 290ACHINOOK THERAPEUTICS INC | 555,155 | $9.1B | 3.29% | |
| 9 | PTGXPROTAGONIST THERAPEUTICS INC | 241,119 | $8.2B | 2.99% | |
| 10 | BBIOBRIDGEBIO PHARMA INC | 494,046 | $8.2B | 2.99% | |
| 11 | —CURIS INC | 1,700,000 | $8.1B | 2.94% | Call |
| 12 | KURAKURA ONCOLOGY INC | 560,000 | $7.8B | 2.85% | |
| 13 | TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | 7,000,000 | $7.7B | 2.81% | |
| 14 | MRNAMODERNA INC | 30,000 | $7.6B | 2.77% | Put |
| 15 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 225,000 | $7.3B | 2.65% | |
| 16 | NVV1NOVAVAX INC | 50,000 | $7.2B | 2.60% | Put |
| 17 | —ARYA SCIENCES ACQUISITN CORP | 702,500 | $6.8B | 2.47% | |
| 18 | CYTKCYTOKINETICS INC | 145,552 | $6.6B | 2.41% | |
| 19 | ACRSACLARIS THERAPEUTICS INC | 400,000 | $5.8B | 2.11% | |
| 20 | RPTXREPARE THERAPEUTICS INC | 271,778 | $5.7B | 2.08% | |
| 21 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 7,500,000 | $5.5B | 2.01% | |
| 22 | MDGLMADRIGAL PHARMACEUTICALS INC | 65,000 | $5.5B | 2.00% | |
| 23 | NAUTNAUTILUS BIOTECHNOLOGY INC | 1,049,721 | $5.4B | 1.97% | |
| 24 | ESTAESTABLISHMENT LABS HLDGS INC | 77,500 | $5.2B | 1.90% | |
| 25 | CNTACENTESSA PHARMACEUTICALS PLC | 419,144 | $4.7B | 1.71% | |
| 26 | XENEXENON PHARMACEUTICALS INC | 150,500 | $4.7B | 1.71% | |
| 27 | BLUBELLUS HEALTH INC NEW | 500,000 | $4.0B | 1.46% | |
| 28 | —ARYA SCIENCES ACQU CORP IV | 400,000 | $4.0B | 1.44% | |
| 29 | TCE2CELLDEX THERAPEUTICS INC NEW | 100,000 | $3.9B | 1.40% | |
| 30 | SNDXSYNDAX PHARMACEUTICALS INC | 175,000 | $3.8B | 1.39% | |
| 31 | CBAYUSDCYMABAY THERAPEUTICS INC | 1,122,244 | $3.8B | 1.38% | |
| 32 | RCKTROCKET PHARMACEUTICALS INC | 165,000 | $3.6B | 1.31% | |
| 33 | —HEALTH SCIENCES ACQ CORP 2 | 300,000 | $3.0B | 1.09% | |
| 34 | —ENVIRONMENTAL IMPACT ACQU CO | 300,000 | $3.0B | 1.08% | |
| 35 | MRTXEURMIRATI THERAPEUTICS INC | 20,000 | $2.9B | 1.07% | |
| 36 | —MEDICUS SCIENCES ACQUISITION | 300,000 | $2.9B | 1.06% | |
| 37 | PRCTPROCEPT BIOROBOTICS CORP | 100,000 | $2.5B | 0.91% | |
| 38 | —SCIENCE 37 HOLDINGS INC | 150,000 | $1.9B | 0.68% | |
| 39 | CVACCUREVAC N V | 50,000 | $1.7B | 0.62% | Call |
| 40 | TVTXTRAVERE THERAPEUTICS INC | 50,000 | $1.6B | 0.56% | |
| 41 | —CYCLACEL PHARMACEUTICALS INC | 400,000 | $1.5B | 0.56% | |
| 42 | ARKGARK ETF TR | 25,000 | $1.5B | 0.56% | Call |
| 43 | NTLAINTELLIA THERAPEUTICS INC | 10,000 | $1.2B | 0.43% | |
| 44 | SEERSEER INC | 50,000 | $1.1B | 0.41% | Call |
| 45 | INOINOVIO PHARMACEUTICALS INC | 200,000 | $998.0M | 0.36% | Call |
| 46 | —RENOVACOR INC | 125,000 | $963.0M | 0.35% | |
| 47 | IMTXIMMATICS N.V | 190,000 | $834.0M | 0.30% | |
| 48 | HYPRHYPERFINE INC | 76,162 | $552.0M | 0.20% | |
| 49 | RFLRAFAEL HLDGS INC | 101,200 | $516.0M | 0.19% | Put |
| 50 | LIANYLIANBIO SPONSORED | 72,406 | $446.0M | 0.16% | |
| 51 | ALDXALDEYRA THERAPEUTICS INC | 100,759 | $403.0M | 0.15% | |
| 52 | IOVAIOVANCE BIOTHERAPEUTICS INC | 20,000 | $382.0M | 0.14% | |
| 53 | —RENOVACOR INC | 75,000 | $43.0M | 0.02% | |
| 54 | —MEDICUS SCIENCES ACQUISITION | 33,333 | $24.0M | 0.01% |